FDA allows imports of syphilis drug alternate during shortage
时间:2024-06-26 07:24:46 阅读(143)
US regulators gave temporary permission for importation of a form of penicillin used to treat syphilis amid a national shortage of Pfizer Inc.’s version of the drug along with a dramatic increase in cases.
The Food and Drug Administration authorized importation of penicillin G benzathine made by a French company, Laboratoires Delbert, according to the agency website. Pfizer’s Bicillin L-A, the only version of the drug available in the US, has been in short supply since April.
While as little as one injection of penicillin G benzathine can cure syphilis, the shortage prompted US health officials to recommend giving some patients doxycycline, another antibiotic therapy that requires of weeks of twice-daily pills. The long treatment regimen raises the risk that patients might not complete it, leaving them sick and potentially infectious to others.
The National Coalition of STD Directors applauded the FDA’s action. “We hope this is the first step toward seeing a resolution to this shortage,” David Harvey, executive director of NCSD, said in a statement. Harvey had previously criticized the federal government’s response.
To fix the shortage, Pfizer has added manufacturing shifts and more than halved production time. The company has invited customers who are having trouble getting the drug to contact them directly. “We continue to supply the market above historical rates, and we are reserving product for emergency needs,” a Pfizer spokesperson said.
The shortage is estimated to last through June, according to the FDA.
Unlike Pfizer’s prefilled syringe, Laboratoires Delbert’s formulation of the drug is a powder that must be mixed and then injected by a health-care provider.
猜你喜欢
- IPO Scorecard for September 2023; Track gains since listing
- Godrej Consumer Products acquires Raymond’s FMCG business for Rs 2,825 crore
- Gold Price Today, 11 August- Gold falls on strong US dollar, bond yields; traders eye US CPI data
- ITC 7th firm to cross Rs 6 trillion in market cap
- Gold likely to touch Rs 70,000 in 2024, say experts
- Islamic State group claims responsibility for a minibus explosion in Afghan capital that killed 5
- Israel says blast near Delhi embassy possibly an ‘attack’, issues safety advisory
- Invest in equity funds for inflation-beating returns, low-risk appetite investors can look at hybrid funds
- Lucknow Metro Expansion- Yogi explores metro extension options to enhance connectivity in Uttar Pradesh